Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy
Reference24 articles.
1. Xu H, Li W, Yang J, Wiviott SD, Sabatine MS, Peterson ED, et al. The China acute myocardial infarction (cami) registry: a national long-term registry-research-education integrated platform for exploring acute myocardial infarction in China. Am Heart J. 2016;175:193–201.
2. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.
3. China Society of Cardiology of Chinese Medical Association. Guideline on the diagnosis and therapy of ST-segment elevation myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi. 2015;43:380–93.
4. Chinese Society of Cardiology of Chinese Medical Association. Guideline and consensus for the management of patients with non-ST-elevation acute coronary syndrome(2016). Zhonghua Xin Xue Guan Bing Za Zhi. 2017;45:359–76.
5. Dagenais G, Pogue J, Fox K, Simoons ML, Yusuf S. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials. Lancet. 2006;368(9535):581–8.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献